Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Shanghai Pulmonary Hospital, Shanghai, China
Memorial Sloan Kettering Cancer Center
Instituto Nacional de Cancerologia de Mexico
Pfizer
Emory University
Sun Yat-sen University
H. Lee Moffitt Cancer Center and Research Institute
Fondazione del Piemonte per l'Oncologia
Stanford University
Fu Jen Catholic University
Palo Alto Veterans Institute for Research
AstraZeneca
Karl Landsteiner University of Health Sciences
Ohio State University Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Tizona Therapeutics, Inc
Institut Bergonié